Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew Powell
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Colorado Cancer Center - Anschutz Cancer Pavilion
Aurora, Colorado, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Mcfarland Clinic Pc-William R Bliss Cancer Center
Ames, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa-Wide Oncology Research Coalition Ncorp
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Spectrum Health at Butterworth Campus
Grand Rapids, Michigan, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- North Shore University Hospital
Manhasset, New York, United States
- Long Island Jewish Medical Center
New Hyde Park, New York, United States
- North Shore-Lij Health System/center for Advanced Medicine
New Hyde Park, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Metrohealth Medical Center
Cleveland, Ohio, United States
- University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Oklahoma Cancer Specialists and Research Institute-Tulsa
Tulsa, Oklahoma, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- Huntsman Cancer Institute/university of Utah
Salt Lake City, Utah, United States
- Carilion Clinic Gynecological Oncology
Roanoke, Virginia, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
- Northwest Hospital
Seattle, Washington, United States
- Pacific Gynecology Specialists
Seattle, Washington, United States
- Seattle Cancer Care Alliance
Seattle, Washington, United States
- Swedish Medical Center-First Hill
Seattle, Washington, United States
- University of Washington Medical Center
Seattle, Washington, United States
- Green Bay Oncology Limited at Saint Mary'S Hospital
Green Bay, Wisconsin, United States
- Green Bay Oncology at Saint Vincent Hospital
Green Bay, Wisconsin, United States
- Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, United States
- Gundersen Lutheran Medical Center
La Crosse, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Jul 2009
- Primary completion
- 16 Jul 2016
- Completion
- 16 Jul 2016
- Last update posted
- 6 Dec 2017
- Registered enrollment
- 45
- Registry id
- NCT00888173
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.